Cargando…

Prevalence of Prediabetes and Diabetes Mellitus Type II in Bipolar Disorder

INTRODUCTION: Bipolar disorder (BD) is characterized by recurrent episodes of depression and mania and affects up to 2% of the population worldwide. Patients suffering from bipolar disorder have a reduced life expectancy of up to 10 years. The increased mortality might be due to a higher rate of som...

Descripción completa

Detalles Bibliográficos
Autores principales: Kittel-Schneider, Sarah, Bury, Daniel, Leopold, Karolina, Haack, Sara, Bauer, Michael, Pfeiffer, Steffi, Sauer, Cathrin, Pfennig, Andrea, Völzke, Henry, Grabe, Hans-Jörgen, Reif, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188755/
https://www.ncbi.nlm.nih.gov/pubmed/32390884
http://dx.doi.org/10.3389/fpsyt.2020.00314
_version_ 1783527360226656256
author Kittel-Schneider, Sarah
Bury, Daniel
Leopold, Karolina
Haack, Sara
Bauer, Michael
Pfeiffer, Steffi
Sauer, Cathrin
Pfennig, Andrea
Völzke, Henry
Grabe, Hans-Jörgen
Reif, Andreas
author_facet Kittel-Schneider, Sarah
Bury, Daniel
Leopold, Karolina
Haack, Sara
Bauer, Michael
Pfeiffer, Steffi
Sauer, Cathrin
Pfennig, Andrea
Völzke, Henry
Grabe, Hans-Jörgen
Reif, Andreas
author_sort Kittel-Schneider, Sarah
collection PubMed
description INTRODUCTION: Bipolar disorder (BD) is characterized by recurrent episodes of depression and mania and affects up to 2% of the population worldwide. Patients suffering from bipolar disorder have a reduced life expectancy of up to 10 years. The increased mortality might be due to a higher rate of somatic diseases, especially cardiovascular diseases. There is however also evidence for an increased rate of diabetes mellitus in BD, but the reported prevalence rates vary by large. MATERIAL AND METHODS: 85 bipolar disorder patients were recruited in the framework of the BiDi study (Prevalence and clinical features of patients with Bipolar Disorder at High Risk for Type 2 Diabetes (T2D), at prediabetic state and with manifest T2D) in Dresden and Würzburg. T2D and prediabetes were diagnosed measuring HBA1c and an oral glucose tolerance test (oGTT), which at present is the gold standard in diagnosing T2D. The BD sample was compared to an age-, sex- and BMI-matched control population (n = 850) from the Study of Health in Pomerania cohort (SHIP Trend Cohort). RESULTS: Patients suffering from BD had a T2D prevalence of 7%, which was not significantly different from the control group (6%). Fasting glucose and impaired glucose tolerance were, contrary to our hypothesis, more often pathological in controls than in BD patients. Nondiabetic and diabetic bipolar patients significantly differed in age, BMI, number of depressive episodes, and disease duration. DISCUSSION: When controlled for BMI, in our study there was no significantly increased rate of T2D in BD. We thus suggest that overweight and obesity might be mediating the association between BD and diabetes. Underlying causes could be shared risk genes, medication effects, and lifestyle factors associated with depressive episodes. As the latter two can be modified, attention should be paid to weight changes in BD by monitoring and taking adequate measures to prevent the alarming loss of life years in BD patients.
format Online
Article
Text
id pubmed-7188755
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-71887552020-05-08 Prevalence of Prediabetes and Diabetes Mellitus Type II in Bipolar Disorder Kittel-Schneider, Sarah Bury, Daniel Leopold, Karolina Haack, Sara Bauer, Michael Pfeiffer, Steffi Sauer, Cathrin Pfennig, Andrea Völzke, Henry Grabe, Hans-Jörgen Reif, Andreas Front Psychiatry Psychiatry INTRODUCTION: Bipolar disorder (BD) is characterized by recurrent episodes of depression and mania and affects up to 2% of the population worldwide. Patients suffering from bipolar disorder have a reduced life expectancy of up to 10 years. The increased mortality might be due to a higher rate of somatic diseases, especially cardiovascular diseases. There is however also evidence for an increased rate of diabetes mellitus in BD, but the reported prevalence rates vary by large. MATERIAL AND METHODS: 85 bipolar disorder patients were recruited in the framework of the BiDi study (Prevalence and clinical features of patients with Bipolar Disorder at High Risk for Type 2 Diabetes (T2D), at prediabetic state and with manifest T2D) in Dresden and Würzburg. T2D and prediabetes were diagnosed measuring HBA1c and an oral glucose tolerance test (oGTT), which at present is the gold standard in diagnosing T2D. The BD sample was compared to an age-, sex- and BMI-matched control population (n = 850) from the Study of Health in Pomerania cohort (SHIP Trend Cohort). RESULTS: Patients suffering from BD had a T2D prevalence of 7%, which was not significantly different from the control group (6%). Fasting glucose and impaired glucose tolerance were, contrary to our hypothesis, more often pathological in controls than in BD patients. Nondiabetic and diabetic bipolar patients significantly differed in age, BMI, number of depressive episodes, and disease duration. DISCUSSION: When controlled for BMI, in our study there was no significantly increased rate of T2D in BD. We thus suggest that overweight and obesity might be mediating the association between BD and diabetes. Underlying causes could be shared risk genes, medication effects, and lifestyle factors associated with depressive episodes. As the latter two can be modified, attention should be paid to weight changes in BD by monitoring and taking adequate measures to prevent the alarming loss of life years in BD patients. Frontiers Media S.A. 2020-04-22 /pmc/articles/PMC7188755/ /pubmed/32390884 http://dx.doi.org/10.3389/fpsyt.2020.00314 Text en Copyright © 2020 Kittel-Schneider, Bury, Leopold, Haack, Bauer, Pfeiffer, Sauer, Pfennig, Völzke, Grabe and Reif http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Kittel-Schneider, Sarah
Bury, Daniel
Leopold, Karolina
Haack, Sara
Bauer, Michael
Pfeiffer, Steffi
Sauer, Cathrin
Pfennig, Andrea
Völzke, Henry
Grabe, Hans-Jörgen
Reif, Andreas
Prevalence of Prediabetes and Diabetes Mellitus Type II in Bipolar Disorder
title Prevalence of Prediabetes and Diabetes Mellitus Type II in Bipolar Disorder
title_full Prevalence of Prediabetes and Diabetes Mellitus Type II in Bipolar Disorder
title_fullStr Prevalence of Prediabetes and Diabetes Mellitus Type II in Bipolar Disorder
title_full_unstemmed Prevalence of Prediabetes and Diabetes Mellitus Type II in Bipolar Disorder
title_short Prevalence of Prediabetes and Diabetes Mellitus Type II in Bipolar Disorder
title_sort prevalence of prediabetes and diabetes mellitus type ii in bipolar disorder
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188755/
https://www.ncbi.nlm.nih.gov/pubmed/32390884
http://dx.doi.org/10.3389/fpsyt.2020.00314
work_keys_str_mv AT kittelschneidersarah prevalenceofprediabetesanddiabetesmellitustypeiiinbipolardisorder
AT burydaniel prevalenceofprediabetesanddiabetesmellitustypeiiinbipolardisorder
AT leopoldkarolina prevalenceofprediabetesanddiabetesmellitustypeiiinbipolardisorder
AT haacksara prevalenceofprediabetesanddiabetesmellitustypeiiinbipolardisorder
AT bauermichael prevalenceofprediabetesanddiabetesmellitustypeiiinbipolardisorder
AT pfeiffersteffi prevalenceofprediabetesanddiabetesmellitustypeiiinbipolardisorder
AT sauercathrin prevalenceofprediabetesanddiabetesmellitustypeiiinbipolardisorder
AT pfennigandrea prevalenceofprediabetesanddiabetesmellitustypeiiinbipolardisorder
AT volzkehenry prevalenceofprediabetesanddiabetesmellitustypeiiinbipolardisorder
AT grabehansjorgen prevalenceofprediabetesanddiabetesmellitustypeiiinbipolardisorder
AT reifandreas prevalenceofprediabetesanddiabetesmellitustypeiiinbipolardisorder